Empower Advisory Group LLC Buys 8,047 Shares of Colgate-Palmolive (NYSE:CL)

Empower Advisory Group LLC grew its position in Colgate-Palmolive (NYSE:CL - Free Report) by 4.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 173,798 shares of the company's stock after purchasing an additional 8,047 shares during the period. Empower Advisory Group LLC's holdings in Colgate-Palmolive were worth $18,042,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $25,000. Continuum Advisory LLC boosted its stake in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth about $53,000. Finally, Gradient Investments LLC boosted its stake in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after acquiring an additional 400 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 16.44 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.34% of the company's stock.

Colgate-Palmolive Stock Up 0.4 %

Shares of CL traded up $0.37 during trading hours on Thursday, hitting $91.44. The stock had a trading volume of 4,705,419 shares, compared to its average volume of 4,374,397. The firm has a market capitalization of $74.71 billion, a P/E ratio of 26.10, a price-to-earnings-growth ratio of 3.27 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 1-year low of $75.17 and a 1-year high of $109.30. The firm has a 50 day simple moving average of $99.94 and a 200-day simple moving average of $98.48.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 57.31%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CL. Piper Sandler began coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an "overweight" rating and a $121.00 target price for the company. Sanford C. Bernstein increased their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research note on Tuesday, July 30th. UBS Group increased their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. Finally, Redburn Atlantic upgraded Colgate-Palmolive to a "hold" rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.